Unknown

Dataset Information

0

Pleiotropy and pathway analyses of genetic variants associated with both type 2 diabetes and prostate cancer.


ABSTRACT: AIMS:Epidemiological evidence shows that diabetes is associated with a reduced risk of prostate cancer. The objective of this study was to identify genes that may contribute to both type 2 diabetes and prostate cancer outcomes and the biological pathways these diseases may share. METHODS:The Atherosclerosis Risk in Communities (ARIC) Study is a population-based prospective cohort study in four U.S. communities that included a baseline examination in 1987-89 and three follow-up exams at three year intervals. Participants were 45-64 years old at baseline. We conducted a genomewide association (GWA) study of incident type 2 diabetes in males, summarized variation across genetic loci into a polygenic risk score, and determined if that diabetes risk score was also associated with incident prostate cancer in the same study population. Secondarily we conducted a separate GWA study of prostate cancer, performed a pathway analysis of both type 2 diabetes and prostate cancer, and qualitatively determined if any of the biochemical pathways identified were shared between the two outcomes. RESULTS:We found that the polygenic risk score for type 2 diabetes was not statistically significantly associated with prostate cancer. The pathway analysis also found no overlap between pathways associated with type 2 diabetes and prostate cancer. However, it did find that the growth hormone signaling pathway was statistically significantly associated with type 2 diabetes (p=0.0001). CONCLUSION:The inability of this study to find an association between type 2 diabetes polygenic risk scores with prostate cancer or biological pathways in common suggests that shared genetic variants may not contribute significantly to explaining shared etiology.

SUBMITTER: Raynor LA 

PROVIDER: S-EPMC3612454 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pleiotropy and pathway analyses of genetic variants associated with both type 2 diabetes and prostate cancer.

Raynor L A LA   Pankow James S JS   Rasmussen-Torvik Laura J LJ   Tang Weihong W   Prizment Anna A   Couper David J DJ  

International journal of molecular epidemiology and genetics 20130318 1


<h4>Aims</h4>Epidemiological evidence shows that diabetes is associated with a reduced risk of prostate cancer. The objective of this study was to identify genes that may contribute to both type 2 diabetes and prostate cancer outcomes and the biological pathways these diseases may share.<h4>Methods</h4>The Atherosclerosis Risk in Communities (ARIC) Study is a population-based prospective cohort study in four U.S. communities that included a baseline examination in 1987-89 and three follow-up exa  ...[more]

Similar Datasets

| S-EPMC7936951 | biostudies-literature
2016-02-27 | E-GEOD-77350 | biostudies-arrayexpress
| S-EPMC3990322 | biostudies-literature
2016-02-27 | GSE77350 | GEO
| S-EPMC3778915 | biostudies-literature
| S-EPMC8590378 | biostudies-literature
| S-EPMC2883345 | biostudies-literature
| S-EPMC6198349 | biostudies-literature
| S-EPMC3143214 | biostudies-literature
| S-EPMC2866577 | biostudies-literature